Mirror Life, Thrice: Three Levels of Mirror Biology and Three Ethical Conditions
Mirror biology is drawing urgent calls for governance, from the WHO to the UN Scientific Advisory Board. Yet the term "mirror life" lumps together phenomena with very different risk-benefit profiles. We distinguish three levels. Mirror molecules already deliver therapeutic benefits at manageable risk; mirror organisms threaten catastrophic and irreversible harm and warrant prohibition; mirror subsystems occupy contested middle ground. For this last category, we propose three conditions that any research with a plausible pathway to catastrophic harm should meet: necessity, commensurate benefit, and intolerable cost of delay. Applied to the mirror ribosome, the principal bottleneck on the path to mirror organisms, none of the three is currently satisfied. Much apparent disagreement in the literature dissolves once we recognize that commentators are addressing different levels of complexity.
Authors
- Julian Savulescu (ORCID: https://orcid.org/0000-0003-1691-6403)
- Brian David Earp (ORCID: https://orcid.org/0000-0001-9691-2888)
- Sebastian Porsdam Mann (ORCID: https://orcid.org/0000-0002-1867-2097)
Institutions
- University of Copenhagen (DK)
- National University of Singapore (SG)
- University of Oxford (GB)
Publication Details
- Journal
- The American Journal of Bioethics
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1080/15265161.2026.2741293
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- National University of Singapore
- Ministry of Education - Singapore
- Novo Nordisk
- Novo Nordisk Fonden